NBRV

Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV

Overview Fund Activity
Delisted

NBRV was delisted on the 31st of July, 2023.

Back to rankings

25 hedge funds and large institutions have $630K invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 6 closing their positions.

Holders
25
Holders Change
-4
Holders Change %
-13.79%
% of All Funds
0.42%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
7
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$145K
2
Citadel Advisors
2
Citadel Advisors
Florida
$33K
3
Jane Street
3
Jane Street
New York
$12K
4
VF
4
Virtu Financial
New York
$23K
5
Morgan Stanley
5
Morgan Stanley
New York
$25K

Top Sellers

1
ACM
1
Aisling Capital Management
New York
$16K
2
JPMPWA
2
J.P. Morgan Private Wealth Advisors
California
$0
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$8K
4
Ameriprise
4
Ameriprise
Minnesota
$0
5
HF
5
HRT Financial
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Group One Trading
26
Group One Trading
Illinois
– – – –
JPLA
27
Joseph P. Lucia & Associates
New York
$0 18 – –
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$0 500 – –
CFGS
29
Concourse Financial Group Securities
Alabama
– – – –
Bank of America
30
Bank of America
North Carolina
$0 1,810 +10 +0.6%
Wells Fargo
31
Wells Fargo
California
$0 125 +125 New
EC
32
Estate Counselors
Wisconsin
$0 440 +440 New
Simplex Trading
33
Simplex Trading
Illinois
$0 700 +475 +211%
1
2